Technology transfer successes
ANSTO's technology commercialisation successes include:
Peripheral Benzodiazepine Receptor (PBR)
This is a protein associated with the mitochondria and is over-represented in tumours, inflammatory lesions and neuro-degenerative diseases. ANSTO has developed a family of chemical analogues with high affinity and selectivity to target the PBR with useful clinical applications, particularly imaging of cancers and diseases such as Alzheimers.
Australian Synchrotron user portal
ANSTO designed a web portal for user access to the Bragg neutron instruments. This portal was then customised and licensed to the Australian Synchrotron for their user access program. Learn more.